Di Bei

578 total citations
16 papers, 448 citations indexed

About

Di Bei is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Di Bei has authored 16 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Di Bei's work include Advanced biosensing and bioanalysis techniques (2 papers), Nanofabrication and Lithography Techniques (2 papers) and HER2/EGFR in Cancer Research (2 papers). Di Bei is often cited by papers focused on Advanced biosensing and bioanalysis techniques (2 papers), Nanofabrication and Lithography Techniques (2 papers) and HER2/EGFR in Cancer Research (2 papers). Di Bei collaborates with scholars based in United States, Switzerland and Denmark. Di Bei's co-authors include Bi‐Botti C. Youan, Jacob M. Marszalek, Guohua An, Jianing Meng, Tao Zhang, James B. Murowchick, Ian M. Catlett, Ihab Girgis, John S. Markowitz and Bindu Murthy and has published in prestigious journals such as Cancer Research, Journal of Neurochemistry and Annals of the Rheumatic Diseases.

In The Last Decade

Di Bei

16 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Di Bei United States	12	153	94	73	70	57	16	448
Alka Madaan India	13	174 1.1×	52 0.6×	53 0.7×	71 1.0×	104 1.8×	17	583
Ahil N. Ganesh Canada	11	211 1.4×	42 0.4×	38 0.5×	94 1.3×	29 0.5×	13	481
Srinivas Jayanthi United States	11	313 2.0×	49 0.5×	34 0.5×	59 0.8×	45 0.8×	31	555
Jason K. Cullen Australia	11	286 1.9×	39 0.4×	42 0.6×	33 0.5×	29 0.5×	22	514
Jack Michel Renoir France	10	373 2.4×	60 0.6×	46 0.6×	85 1.2×	94 1.6×	11	635
Vivek Makwana Australia	8	235 1.5×	104 1.1×	42 0.6×	85 1.2×	48 0.8×	10	436
Jean‐Marc Grognet France	10	187 1.2×	35 0.4×	42 0.6×	91 1.3×	34 0.6×	24	471
Hongxia Lin South Korea	8	114 0.7×	156 1.7×	82 1.1×	72 1.0×	24 0.4×	9	464
Tracy J Worzella United States	8	256 1.7×	20 0.2×	63 0.9×	52 0.7×	41 0.7×	14	596
Hai Hua Jiang South Korea	10	342 2.2×	109 1.2×	50 0.7×	190 2.7×	44 0.8×	13	628

Countries citing papers authored by Di Bei

Since Specialization

Citations

This map shows the geographic impact of Di Bei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Bei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Bei more than expected).

Fields of papers citing papers by Di Bei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Bei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Bei. The network helps show where Di Bei may publish in the future.

Co-authorship network of co-authors of Di Bei

This figure shows the co-authorship network connecting the top 25 collaborators of Di Bei. A scholar is included among the top collaborators of Di Bei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Bei. Di Bei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Catlett, Ian M., Lars Hansen, Yali Liu, et al.. (2022). First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2. Clinical and Translational Science. 16(1). 151–164. 37 indexed citations

Bei, Di, et al.. (2019). Benefit‐risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers. Cancer Science. 111(2). 528–535. 12 indexed citations

Catlett, Ian M., et al.. (2017). SAT0226 A first-in-human, study of BMS-986165, a selective, potent, allosteric small molecule inhibitor of tyrosine kinase 2. Annals of the Rheumatic Diseases. 76. 859–859. 20 indexed citations

Bei, Di & Guohua An. (2015). Pharmacokinetics and tissue distribution of 5,7-dimethoxyflavone in mice following single dose oral administration. Journal of Pharmaceutical and Biomedical Analysis. 119. 65–70. 22 indexed citations

Shao, Jie, John S. Markowitz, Di Bei, & Guohua An. (2014). Enzyme-Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors. Journal of Pharmaceutical Sciences. 103(12). 3810–3833. 33 indexed citations

Bei, Di & Guohua An. (2014). Quantification of 5,7-dimethoxyflavone in mouse plasma using liquid chromatography–tandem mass spectrometry (LC–MS/MS) and its application to a pharmacokinetic study. Journal of Chromatography B. 978-979. 11–17. 5 indexed citations

Aarnes, Turi K., John A. E. Hubbell, Richard M. Bednarski, et al.. (2013). Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas. American Journal of Veterinary Research. 74(2). 294–299. 9 indexed citations

Bei, Di, et al.. (2013). Abstract 4879: Determination of chebulagic acid and chebulinic acid and their pharmacokinetics in mouse .. Cancer Research. 73(8_Supplement). 4879–4879. 3 indexed citations

Chen, Wei, Dian Wang, Li‐Shu Wang, et al.. (2012). Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC–tandem mass spectrometry. Journal of Chromatography B. 908. 39–44. 33 indexed citations

10.

Bei, Di, Tao Zhang, James B. Murowchick, & Bi‐Botti C. Youan. (2010). Formulation of Dacarbazine-loaded Cubosomes. Part III. Physicochemical Characterization. AAPS PharmSciTech. 11(3). 1243–1249. 50 indexed citations

11.

Bei, Di, Jianing Meng, & Bi‐Botti C. Youan. (2010). Engineering Nanomedicines for Improved Melanoma Therapy: Progress and Promises. Nanomedicine. 5(9). 1385–1399. 67 indexed citations

12.

Bei, Di, Jacob M. Marszalek, & Bi‐Botti C. Youan. (2009). Formulation of Dacarbazine-Loaded Cubosomes—Part I: Influence of Formulation Variables. AAPS PharmSciTech. 10(3). 1032–9. 69 indexed citations

13.

Bei, Di, Jacob M. Marszalek, & Bi‐Botti C. Youan. (2009). Formulation of Dacarbazine-loaded Cubosomes—Part II: Influence of Process Parameters. AAPS PharmSciTech. 10(3). 1040–7. 34 indexed citations

14.

Cheon, Keun‐Ah, Jiangang Gao, Steven Nusinowitz, et al.. (2002). Progressive Photoreceptor Degeneration, Outer Segment Dysplasia and Rhodopsin Mislocalization in Mice with Targeted Disruption of the Retinitis Pigmentosa-1 (Rp1) Gene. 43(13). 3667–3667. 5 indexed citations

15.

Liu, Dong, Di Bei, Hema Parmar, & Andrew Matus. (2000). Activity-regulated, cytoskeleton-associated protein (Arc) is essential for visceral endoderm organization during early embryogenesis. Mechanisms of Development. 92(2). 207–215. 15 indexed citations

16.

Johnstone, Mandy, Robert Goold, Di Bei, Itzhak Fischer, & Phillip R. Gordon‐Weeks. (1997). Localisation of Microtubule‐Associated Protein 1B Phosphorylation Sites Recognised by Monoclonal Antibody SMI‐31. Journal of Neurochemistry. 69(4). 1417–1424. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact